Provided by Tiger Trade Technology Pte. Ltd.

Fennec Pharmaceuticals Inc.

11.37
-0.2832-2.43%
Volume:60.77K
Turnover:700.24K
Market Cap:398.60M
PE:-94.72
High:11.73
Open:11.51
Low:11.33
Close:11.65
52wk High:13.25
52wk Low:5.65
Shares:35.07M
Float Shares:19.89M
Volume Ratio:0.41
T/O Rate:0.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1200
EPS(LYR):-0.3409
ROE:-18.58%
ROA:-1.16%
PB:9.39
PE(LYR):-33.35

Loading ...

Fennec Pharmaceuticals Price Target Maintained with a $16.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 09

Fennec Pharma Former Director Rosty Raykov Disposes of 10,000 Common Shares for $121,100

Reuters
·
Sep 02

Fennec Pharmaceuticals CFO Robert Andrade Sells 75,000 Common Shares for $883,500

Reuters
·
Aug 29

Fennec Pharmaceuticals Publishes Corporate Presentation Highlighting Pedmark Expansion for Cisplatin-Induced Hearing Loss Prevention

Reuters
·
Aug 18

Fennec Pharmaceuticals (FENC) Gets a Buy from Maxim Group

TIPRANKS
·
Aug 13

Fennec Pharmaceuticals is Maintained at Outperform by Wedbush

Dow Jones
·
Aug 13

Fennec Pharmaceuticals (FENC) Gets a Buy from Wedbush

TIPRANKS
·
Aug 12

B. Riley Adjusts Fennec Pharmaceuticals Price Target to $18 From $16, Maintains Buy Rating

MT Newswires Live
·
Aug 12

Canada's Cipher Pharma Q2 Revenue Falls on Lower Natroba Sales Amid Reduced Medicaid Coverage

Reuters
·
Aug 12

Aquestive Therapeutics Q2 Revenue Beats on Suboxone Strength

Reuters
·
Aug 12

Wedbush Adjusts Fennec Pharmaceuticals PT to $16 From $13, Maintains Outperform Rating

MT Newswires Live
·
Aug 11

Fennec Pharmaceuticals Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

Fennec Pharmaceuticals Q2 Sales Rise on Pedmark Demand

Reuters
·
Aug 11

Fennec Pharmaceuticals Q2 EPS $0.05 Beats $0.02 Estimate, Sales $17.874M Beat $16.095M Estimate

Benzinga Earnings
·
Aug 11

Fennec Pharmaceuticals Q2 Product Sales USD 17.164 Million

THOMSON REUTERS
·
Aug 11

Fennec Pharmaceuticals Q2 EPS USD $0.05

THOMSON REUTERS
·
Aug 11

Fennec Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
Aug 11

Fennec Pharmaceuticals Inc. Expected to Post Earnings of 1 Cent a Share - Earnings Preview

Reuters
·
Aug 07

Fennec Pharmaceuticals Schedules Second-Quarter 2026 Results Call

Reuters
·
Aug 05

Fennec Pharmaceuticals Former Director Rosty Raykov Disposes of 10,000 Common Shares Worth $95,800

Reuters
·
Aug 05